ReviewEndocrine, metabolic & immune disorders drug targets2026

Diabetic Ketoacidosis: Considerations and Residual Controversies in Management After the 2024 ADA, EASD, JBDS, AACE, and DST Joint Consensus

A Ciafardini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.